These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 18089415)

  • 21. Crossmatching on platelets by flow cytometry.
    Wang GX; Terashita GY; Terasaki PI
    Clin Transpl; 1988; ():381-5. PubMed ID: 3154488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation.
    Bingaman AW; Murphey CL; Palma-Vargas J; Wright F
    Transplantation; 2008 Dec; 86(12):1864-8. PubMed ID: 19104435
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Anti-HLA class II antibodies in kidney retransplant patients.
    Arnold ML; Pei R; Spriewald B; Wassmuth R
    Tissue Antigens; 2005 Apr; 65(4):370-8. PubMed ID: 15787721
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of antithymocyte globulin on anti-human leukocyte antigen antibody detection assays.
    Gloor JM; Moore SB; Schneider BA; Degoey SR; Stegall MD
    Transplantation; 2007 Jul; 84(2):258-64. PubMed ID: 17667819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The virtual crossmatch--a screening tool for sensitized pediatric heart transplant recipients.
    Zangwill SD; Ellis TM; Zlotocha J; Jaquiss RD; Tweddell JS; Mussatto KA; Berger S
    Pediatr Transplant; 2006 Feb; 10(1):38-41. PubMed ID: 16499585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HLA antibodies in renal transplant candidates.
    Lenhartová E; Lenhart K; Bártová A; Loucková I
    Acta Univ Palacki Olomuc Fac Med; 1992; 134():81-3. PubMed ID: 1364974
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of anti-HLA antibodies eluted from explanted renal allografts.
    Heinemann FM; Roth I; Rebmann V; Arnold ML; Spriewald BM; Grosse-Wilde H
    Clin Transpl; 2006; ():371-8. PubMed ID: 18365391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction of crossmatch outcome of highly sensitized patients by single and/or multiple antigen bead luminex assay.
    Vaidya S; Partlow D; Susskind B; Noor M; Barnes T; Gugliuzza K
    Transplantation; 2006 Dec; 82(11):1524-8. PubMed ID: 17164726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Flow cytometry crossmatching: a method for monitoring antidonor antibodies in heart transplant recipients.
    Hurley JP; Cook DJ; McCarthy PM; Hobbs RE; Koo AP; Ratliff NB; Klingman LL; Mrzena K; Stewart RW
    Transplant Proc; 1995 Feb; 27(1):1301-2. PubMed ID: 7878891
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
    Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
    Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Products of HLA class I and class II (B,C,DP,DQ,DR) genes all contribute to induction of recipient anti-donor responses in rejected kidneys.
    Bonneville M; Moreau JF; Blokland E; Pool J; Charron D; Goulmy E; Soulillou JP
    Transplant Proc; 1988 Apr; 20(2):193-5. PubMed ID: 3284038
    [No Abstract]   [Full Text] [Related]  

  • 32. Simultaneous detection of antibody binding and cytotoxicity in flow cytometry crossmatch for renal transplantation.
    Won DI; Jeong HD; Kim YL; Suh JS
    Cytometry B Clin Cytom; 2006 Mar; 70(2):82-90. PubMed ID: 16470535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Flow cytometric detection of complement-activating HLA antibodies.
    Schönemann C; Lachmann N; Kiesewetter H; Salama A
    Cytometry B Clin Cytom; 2004 Nov; 62(1):39-45. PubMed ID: 15476206
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M; Hung CJ; Lin YJ; Chang SS; Chou TC
    Transplant Proc; 2009; 41(1):95-8. PubMed ID: 19249487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical importance of anti-human leukocyte antigen-specific antibody concentration in performing calculated panel reactive antibody and virtual crossmatches.
    Vaidya S
    Transplantation; 2008 Apr; 85(7):1046-50. PubMed ID: 18408587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Improved specificity and sensitivity when using pronase-digested lymphocytes to perform flow-cytometric crossmatch prior to renal transplantation.
    Lobo PI; Isaacs RB; Spencer CE; Pruett TL; Sanfey HA; Sawyer RG; McCullough C
    Transpl Int; 2002 Nov; 15(11):563-9. PubMed ID: 12461661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Successful deceased-donor kidney transplantation in crossmatch-positive patients with peritransplant plasma exchange and Rituximab.
    Beimler JH; Morath C; Schmidt J; Ovens J; Opelz G; Rahmel A; Zeier M; Süsal C
    Transplantation; 2009 Mar; 87(5):668-71. PubMed ID: 19295310
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histocompatibility testing in clinical renal transplantation.
    Braun WE
    Urol Clin North Am; 1983 May; 10(2):231-42. PubMed ID: 6222529
    [No Abstract]   [Full Text] [Related]  

  • 40. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.